FDA Adverse Event Injury Summary report: N

GYNECARE PROLIFT POSTERIOR PELVIC FLOOR REPAIR SYSTEM

MDR report key: 5456478 · Received February 24, 2016

Report

Report Number
2210968-2015-19060
Event Type
Injury
Date Received
February 24, 2016
Report Date
November 10, 2015
Manufacturer
ETHICON INC.
Product Code
OTP
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). TO DATE, THE DEVICE HAS NOT BEEN RETURNED. IF THE PRODUCT IS RETURNED FOR EVALUATION, ANY FURTHER INFO DERIVED FROM THE EVALUATION WILL BE SUBMITTED IN A SUPPLEMENTAL 3500A FORM. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA. E2013037. TOTAL NUMBER OF EVENTS: 374. GYNECARE PROLIFT +M ANTERIOR PELVIC FLOOR REPAIR SYSTEM 13. GYNECARE PROLIFT +M PELVIC FLOOR REPAIR SYSTEM 18. GYNECARE PROLIFT +M POSTERIOR PELVIC FLOOR REPAIR SYSTEM 9. GYNECARE PROLIFT +M TOTAL PELVIC FLOOR REPAIR SYSTEM 35. GYNECARE PROLIFT ANTERIOR PELVIC FLOOR REPAIR SYSTEM 40. GYNECARE PROLIFT PELVIC FLOOR REPAIR SYSTEM 147. GYNECARE PROLIFT POSTERIOR PELVIC FLOOR REPAIR SYSTEM 24. GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM 58. GYNECARE PROSIMA PELVIC FLOOR REPAIR SYSTEM 13. GYNECARE PROSIMA PELVIC FLOOR REPAIR SYSTEMS 17.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ADDITIONAL F-10 PATIENT CODES: 1928, 1930, 2060, 2597, 3191. ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD (B)(4) 2015 THROUGH (B)(4) 2016.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Additional Manufacturer Narrative · 0

ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Description of Event or Problem · 0

IT WAS REPORTED BY ATTORNEY THAT THE PATIENT UNDERWENT A GYNECOLOGICAL SURGICAL PROCEDURE ON (B)(6) 2012 CONCURRENTLY WITH BLADDER HYDRODISTENTION AND PERINEOPLASTY AND MESH WAS IMPLANTED. IT WAS REPORTED THAT, FOLLOWING THE PROCEDURE, THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES. IT WAS REPORTED THAT THE PATIENT UNDERWENT A MESH REMOVAL ON (B)(6) 2013 DUE TO RECTAL PROLAPSE, DYSPAREUNIA AND EROSION.

Additional Manufacturer Narrative · 1

DATE SENT TO FDA: 04/24/2019. ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Additional Manufacturer Narrative · 1

DATE SENT TO FDA: 12/27/2018. ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Additional Manufacturer Narrative · 1

DATE SENT TO FDA: 02/12/2019. ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037. REPORTING PERIOD DECEMBER 1, 2015 THROUGH JANUARY 31, 2016.

Additional Manufacturer Narrative · 1

DATE SENT TO FDA: (B)(4) 2018. ETHICON MDR SUMMARY REPORTING EXEMPTION E2013037REPORTING PERIOD (B)(4) 2015 THROUGH (B)(4) 2016.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
114778 GYNECARE PROLIFT POSTERIOR PELVIC FLOOR REPAIR SYSTEM MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC OTP ETHICON INC. UNK 3515542

Patients

Seq Age Sex Outcome Treatment
1 50 YR Required Intervention